Has Much Changed For Multinational Healthcare Companies In Myanmar?

During our 2013 study of Myanmar’s healthcare system, we managed to meet with both policy makers and multinational pharmaceutical and device companies who were eager to see a viable market for healthcare goods and services evolve.  It would be fair to say that in hindsight, most people from both the public and private sector were fairly bullish both on the country’s healthcare-specific growth prospects as well as overall political reform.  Now, almost eighteen months later, I wanted to return to these points and see how the market is evolving, and what the implications are for multinationals.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news